Educational materials for healthcare professionals
Find educational materials on therapeutic products and cell, tissue or gene therapy products (CTGTP) intended for healthcare professionals or directed at their patients.
Overview
The educational materials listed below highlight specific safety concerns associated with the use of selected therapeutic products and CTGTP, and provide advice on the actions required to optimise the safe and effective use of these products.
Physician Educational Material (PEM): Intended for use by healthcare professionals in conjunction with the approved Singapore package insert. The PEM highlights safety concerns associated with the product and their risk mitigation measures e.g. selection of the appropriate patient group, close adherence to the recommended dosing information, close monitoring for early signs of adverse events that could require therapy modification.
Patient Medication Guide (PMG) and Patient Alert Card (PAC): Intended for dissemination by healthcare professionals to their patients or patients’ caregivers. The PMG and PAC provide important information for patients and their caregivers regarding the use of the product e.g. self-monitoring for early signs and symptoms of adverse events, when to seek prompt medical attention.
Only HSA-approved educational materials are listed below. These materials are published with the agreement of the company responsible for producing them, and are not intended to replace medical advice offered by healthcare professionals.
For electronic package inserts accessed from QR codes printed on the educational materials, there may be a time lag in the publishing of the latest approved package inserts after revisions are approved by HSA. Healthcare professionals should refer to HSA's website for the latest approved package insert for the product.
Search by brand name or active ingredient using the “Find” tool on your browser
Active ingredient(s) | Brand name | Company | Educational material(s) |
|---|---|---|---|
Ambrisentan | Volibris | GlaxoSmithKline Pte Ltd | |
Apixaban | Eliquis | Pfizer Private Limited | |
Apixaban | Apigat | Natco Pharma Asia Pte Ltd | |
Apixaban | Hemapix | Sandoz Singapore Pte Ltd | Hemapix PAC Material will be available soon |
Atezolizumab | Tecentriq | Roche Singapore Pte Ltd | |
Avelumab | Bavencio | Merck Pte Ltd | |
Axicabtagene ciloleucel | Yescarta | Gilead Sciences Singapore Pte Ltd | Yescarta PEM Physician (opens in new tab) Yescarta PEM HandlingAdminGuide (opens in new tab) |
Belantamab mafodotin | Blenrep | GlaxoSmithKline Pte Ltd | |
Bosentan | Proart | Ranbaxy (Malaysia) Sdn Bhd | |
Brexucabtagene autoleucel | Tecartus | Gilead Sciences Singapore Pte Ltd | Tecartus PEM Physician (opens in new tab) Tecartus PEM HandlingAdminGuide (opens in new tab) |
Dabigatran | Pradaxa | Boehringer Ingelheim Singapore Pte Ltd | |
Dabigatran | Leaxolar | Lotus International Pte Ltd | |
Daratumumab | Darzalex | Johnson & Johnson International (Singapore) Pte Ltd | Darzalex PEM Physician (opens in new tab) |
Deferasirox | Jadenu | Novartis (Singapore) Pte Ltd | |
Deferasirox | Deferox | Chemkraft Pte Ltd | Deferox PMG Material will be available soon |
Deferasirox | Desroxia | Lotus International Pte Ltd | |
Deferasirox | Ferasiro | Goldplus Universal Pte Ltd | |
Donanemab | Lormalzi | DKSH Singapore Pte Ltd | |
Dostarlimab | Jemperli | GlaxoSmithKline Pte Ltd | |
Durvalumab | Imfinzi | AstraZeneca Singapore Pte Ltd | |
Eculizumab | Soliris | AstraZeneca Singapore Pte Ltd | Soliris PEM (opens in new tab) |
Edoxaban | Lixiana | A. Menarini Singapore Pte Ltd | |
Elranatamab | Elrexfio | Pfizer Private Limited | |
Emicizumab | Hemlibra | Roche Singapore Pte Ltd | |
Epcoritamab | Epkinly | Abbvie Pte Ltd | |
Equecabtagene autoleucel | Fucaso | IASO BIO SGP Pte Ltd | Fucaso PEM Handling & Admin (opens in new tab) |
Esketamine | Spravato | Johnson & Johnson International (Singapore) Pte Ltd | Spravato PEM (opens in new tab) |
Etranacogene dezaparvovec | Hemgenix | CSL Behring Pte Ltd | |
Etrasimod | Velsipity | Everest Medicines (Singapore) Pte Ltd | Velsipity PEM (opens in new tab) |
Fingolimod | Gilenya | Novartis (Singapore) Pte Ltd | Gilenya PEM (opens in new tab) |
Fingolimod | Fincord | Accord Healthcare Private Limited | Fincord PEM (opens in new tab) |
Gilteritinib | Xospata | Astellas Pharma Singapore Pte Ltd | |
Glofitamab | Columvi | Roche Singapore Pte Ltd | |
Ipilimumab | Yervoy | Bristol-Myers Squibb (Singapore) Pte Ltd | |
Iptacopan | Fabhalta | Novartis (Singapore) Pte Ltd | Fabhalta PEM (opens in new tab) |
Isatuximab | Sarclisa | Sanofi-aventis Singapore Pte Ltd | |
Ivosidenib | Tibsovo | Servier (S) Pte Ltd | |
Lecanemab | Leqembi | Eisai (Singapore) Pte Ltd | |
Lenalidomide | Revlimid | Bristol-Myers Squibb (Singapore) Pte Ltd | Revlimid PEM (opens in new tab) |
Lenalidomide | Leavdo | Pharm-D Singapore Private Limited | |
Lenalidomide | Lenalidomide Grindeks | Goldplus Universal Pte Ltd | |
Lenalidomide | Lenalidomide-Teva | Teva Pharmaceutical Investments Singapore Pte Ltd | |
Lenalidomide | Lenangio | Zyfas Pharma Pte Ltd | |
Lenalidomide | Lenli | Lotus International Pte Ltd | |
Lenalidomide | Linadex | Hetero Singapore Pte Ltd | |
Lenalidomide | Myolid | DKSH Singapore Pte Ltd | |
Leuprorelin | Eligard | DCH Auriga Singapore | |
Macitentan | Opsumit | Johnson & Johnson International (Singapore) Pte Ltd | Opsumit PAC (opens in new tab)
|
Macitentan, Tadalafil | Opsynvi | Johnson & Johnson International (Singapore) Pte Ltd | Opsynvi PAC (opens in new tab)
|
Mavacamten | Camzyos | Bristol-Myers Squibb (Singapore) Pte Ltd | Camzyos PEM (opens in new tab) |
Mosunetuzumab | Lunsumio | Roche Singapore Pte Ltd | |
Natalizumab | Tysabri | Eisai (Singapore) Pte Ltd | |
Nivolumab | Opdivo | Bristol-Myers Squibb (Singapore) Pte Ltd | |
Nivolumab, Relatlimab | Opdualag | Bristol-Myers Squibb (Singapore) Pte Ltd | |
Onasemnogene abeparvovec | Zolgensma | Novartis (Singapore) Pte Ltd | |
Pembrolizumab | Keytruda | MSD Pharma (Singapore) Pte Ltd | |
Pomalidomide | Pomalyst | Bristol-Myers Squibb (Singapore) Pte Ltd | Pomalyst PEM (opens in new tab) |
Pomalidomide | Pomagen | Lotus International Pte Ltd | Pomagen PEM (opens in new tab) |
Ravulizumab | Ultomiris | AstraZeneca Singapore Pte Ltd | Ultomiris PEM (opens in new tab) |
Rivaroxaban | Xarelto | Bayer (South East Asia) Pte Ltd | |
Rivaroxaban | Estaelto | Wellesta Healthcare (Singapore) Pte Ltd | |
Rivaroxaban | Invarox | Intega Pte Ltd | |
Rivaroxaban | Ixobran | Goldplus Universal Pte Ltd | Ixobran PAC Material will be available soon |
Rivaroxaban | Jbrivo | United Italian Trading Corporation (Private) Limited | |
Rivaroxaban | Oranxa | Ranbaxy (Malaysia) Sdn Bhd | Oranxa PAC Material will be available soon |
Rivaroxaban | Rivaroxaban-Teva | Teva Pharmaceutical Investments Singapore Pte Ltd | Rivaroxaban-Teva PAC (opens in new tab) |
Rivaroxaban | Rivason | Alma-A Pte Ltd | |
Rivaroxaban | Rivoban | Chemkraft Pte Ltd | |
Rivaroxaban | Xabarem | Goldplus Universal Pte Ltd | |
Rivaroxaban | Xafariv | Viatris Private Limited | |
Rivaroxaban | Xarid | Zyfas Pharma Pte Ltd | Xarid PAC Material will be available soon |
Rivaroxaban | Zyroxaban | Apex Pharma Marketing Pte Ltd | |
Serplulimab | Zerpidio | Innogene Kalbiotech Pte Ltd | |
Siponimod | Mayzent | Novartis (Singapore) Pte Ltd | Mayzent PEM (opens in new tab) |
Spheroids of human autologous matrix-associated chondrocytes | SpheChon | ReLive Biotechnologies Pte Ltd | |
Tagraxofusp | Elzonris | A. Menarini Singapore Pte Ltd | |
Talquetamab | Talvey | Johnson & Johnson International (Singapore) Pte Ltd |
|
Tarlatamab | Imdelltra | Amgen Biotechnology Singapore Pte Ltd | |
Teclistamab | Tecvayli | Johnson & Johnson International (Singapore) Pte Ltd | |
Teprotumumab | Tepezza | Amgen Biotechnology Singapore Pte Ltd | |
Thalidomide | Domide | Pharm-D Singapore Private Limited | |
Tisagenlecleucel | Kymriah | Novartis (Singapore) Pte Ltd | Kymriah PEM Physician (opens in new tab) Kymriah PEM PharmLabInf (opens in new tab) |
Tislelizumab | Tevimbra | BeOne Medicines Singapore Pte Ltd | |
Tolvaptan | Jinarc | Otsuka Pharmaceuticals (Singapore) Pte Ltd | |
Toripalimab | Loqtorzi | TA Biosciences Pte Ltd | |
Tremelimumab | Imjudo | AstraZeneca Singapore Pte Ltd | |
Voretigene neparvovec | Luxturna | Novartis (Singapore) Pte Ltd | Luxturna PEM Surgical Manual (opens in new tab) Luxturna PEM Pharmacy Manual (opens in new tab) Luxturna PMG (opens in new tab) Luxturna PAC (opens in new tab) Note: Audio version of the PMG and PAC are available online. Please refer to the educational materials for the weblink. |
